AI assistant
Podravka d.d. — Interim / Quarterly Report 2011
Oct 28, 2011
2084_10-q_2011-10-28_60880151-adc5-4212-b3bc-cfb67d480b2d.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
| Appendix 1 Reporting period: |
01.01.2011. do |
30.09.2011. |
|---|---|---|
| Quarterly financial report of entrepreneur - TFI-POD | ||
| Registration number (MB) 03454088 |
||
| Identification number of subject 010006549 |
||
| Personal identification number 18928523252 |
||
| (OIB) Issueer company: PODRAVKA prehrambena industrija d.d., KOPRIVNICA |
||
| Postal code and place 48000 |
KOPRIVNICA | |
| Street and number ANTE STARČEVIĆA 32 | ||
| E-mail address: [email protected] | ||
| Internet adress: www.podravka.com | ||
| Code and name of comune/town KOPRIVNICA 201 |
||
| Code and county name 6 |
KOPRIVNIČKO-KRIŽEVAČKA | Number of employees 6.695 |
| Consolidated statement Yes |
(at quarter end) NKD/NWC code: 1039 |
|
| Subsidiaries subject to consolidation (according to IFRS): | Registration number: | |
| BELUPO d.d. | Koprivnica | 3805140 |
| DANICA d.o.o. | Koprivnica | 0991279 |
| ITAL-ICE d.o.o. | Poreč | 3746011 |
| PODRAVKA POLSKA SP z.o.o. | Kostrzyn, Poljska | 5981449907 |
| PODRAVKA LAGRIS a.s. | Dolni Lhota u Luhačovic, Češka | 3042510487 |
| PODRAVKA SARAJEVO d.o.o. | Sarajevo, BIH | 20188537 |
| Book keeping service: | ||
| Contact person: Celiščak Draga (fill in only surname and name of contact person) |
||
| Phone number: 048 651 200 | Fascimile: 048 651 805 | |
| E-mail address: [email protected] | ||
| Surname and name Vitković Miroslav (authorised person for representation) |
||
| Disclosure documents: shareholders' equity and notes to the financial statements 2. Statement of responsible persons for preparation of financial statements 3. Report of the Management Board on position of the Company |
1. Financial statements (balance sheet, profit and loss account, cash flow statement, statement of changes in PREHRAMBENA INDUSTRIVA d.d. KOPRIVNICA |
173 |
| M.P. | (signed by authorised person for representation) | |
$\mathcal{L}^{\text{max}}$
BALANCE SHEET
as at 30.09.2011.
| Item | Last year (net) | Current year (net) |
|
|---|---|---|---|
| 1 | $\overline{2}$ | 3 | 4 |
| ASSETS | |||
| A) RECEIVABLES FOR SUBSCRIBED BUT NOT PAID-IN CAPITAL | 001 | ||
| B) LONG-TERM ASSETS (003+010+020+029+033) | 002 | 2.056.625.198 | 2.005.681.413 |
| I. INTANGIBLE ASSETS (004 to 009) | 003 | 352.332.661 | 354.679.451 |
| 1. Assets development | 004 | 4.235.380 | 5.809.445 |
| 2. Concessions, patents, licences fees, trade and service marks, software and other rights | 005 | 285.308.114 | 281.105.351 |
| 3. Goodwill | 006 | 44.293.000 | 44.293.000 |
| 4. Prepayments for purchase of intangible assets | 007 | $\mathbf{0}$ | $\mathbf 0$ |
| 5. Intangible assets in preparation | 008 | 18,496,167 | 23.471.655 |
| 6. Other intangible assets | 009 | $\mathbf{0}$ | $\Omega$ |
| II. TANGIBLE ASSETS (011 to 019) | 010 | 1.642.820.313 | 1.593.507.673 |
| 1. Land | 011 | 176.061.299 | 175.072.182 |
| 2. Buildings | 012 | 966.278.616 | 926.326.421 |
| 3. Plant and equipment | 013 | 418.780.995 | 397.091.805 |
| 4. Tools, facility inventory and transport assets 5. Biological assets |
014 | 23.292.232 0 |
21.671.308 |
| 6. Prepayments for tangible assets | 015 | 5.361.777 | 7.108.338 |
| 7. Tangible assets in progress | 016 017 |
49.188.929 | 62.392.358 |
| 8. Other tangible assets | 018 | 3.856.465 | 3.845.261 |
| 9. Investments in buildings | 019 | $\mathbf{0}$ | 0 |
| III. LONG-TERM FINANCIAL ASSETS (021 to 028) | 020 | 9.142.431 | 6,897,040 |
| 1. Investments (shares) with related parties | 021 | $\mathbf{0}$ | 0 |
| 2. Loans given to related parties | 022 | $\mathbf{0}$ | $\Omega$ |
| 3. Participating interest (shares) | 023 | 330.000 | 330.000 |
| 4. Loans to entrepreneurs in whom the entity holds participating interests | 024 | $\mathbf{0}$ | $\Omega$ |
| 5. Investments in securities | 025 | 1.274.116 | 1.292.358 |
| 6. Loans, deposits and similar assets | 026 | 7.538.295 | 5.274.682 |
| 7. Other long - term financial assets | 027 | 20 | 0 |
| 8. Investments accounted by equity method | 028 | $\mathsf 0$ | 0 |
| IV. RECEIVABLES (030 to 032) | 029 | $\mathbf{0}$ | $\overline{0}$ |
| 1. Receivables from related parties | 030 | $\mathbf 0$ | 0 |
| 2. Receivables from based on trade loans | 031 | $\mathbf{0}$ | $\mathbf 0$ |
| 3. Other receivables | 032 | $\Omega$ | |
| V. DEFERRED TAX ASSETS | 033 | 52.329.793 | 50.597.249 |
| C) SHORT TERM ASSETS (035+043+050+058) | 034 | 1.933.337.889 | 1.984.791.318 |
| I. INVENTORIES (036 to 042) | 035 | 692.093.776 | 765.479.104 |
| 1. Raw-material and supplies | 036 | 222.393.816 | 237.876.627 |
| 2. Work in progress | 037 | 36.289.847 | 60.254.129 |
| 3. Finished goods | 038 | 246.637.351 | 273.638.960 |
| 4. Merchandise | 039 | 186.772.762 | 193.709.388 |
| 5. Prepayments for inventories | 040 | $\Omega$ | $\mathbf 0$ |
| 6. Long - term assets held for sales | 041 | $\mathsf 0$ | 0 |
| 7. Biological assets | 042 | $\Omega$ | $\Omega$ |
| II. RECEIVABLES (044 to 049) | 043 | 991.603.792 | 1.026.643.761 |
| 1. Receivables from related parties | 044 | 0 | |
| 2. Accounts receivable | 045 | 946.272.822 | 967.451.282 |
| 3. Receivables from participating parties | 046 | $\mathbf{0}$ | |
| 4. Receivables from employees and members of related parties | 047 | 2.518.619 | 1.899.858 |
| 5. Receivables from government and other institutions | 048 | 34.687.811 | 38.605.967 |
| 6. Other receivables | 049 | 8.124.540 | 18.686.654 |
| III. SHORT TERM FINANCIAL ASSETS (051 to 057) | 050 | 97.276.862 | 68.869.329 |
| 1. Shares (stocks) in related parties | 051 | 0 | |
| 2. Loans given to related parties | 052 | $\mathbf 0$ | 0 |
| 3. Participating interests (shares) | 053 | $\mathbf 0$ | 0 |
| 4. Loans to entrepreneurs in whom the entity holds participating interests | 054 | $\mathbf 0$ | 0 |
| 5. Investments in securities 6. Loans, deposits, etc. |
055 | 41.935.216 | 12.627.898 |
| 7. Other financial assets | 056 | 46.170.596 9.171.050 |
46.808.920 9.432.511 |
| IV. CASH AT BANK AND IN CASHIER | 057 058 |
152.363.459 | 123.799.124 |
| D) PREPAID EXPENSES AND ACCRUED REVENUE | 059 | 18.226.022 | 20.200.850 |
| E) TOTAL ASSETS (001+002+034+059) | 060 | 4.008.189.109 | 4.010.673.581 |
| F) OFF-BALANCE RECORDS | 061 | 807.562.291 | 862.716.916 |
| Item | AOP code |
Last year (net) | Current year (net) |
|---|---|---|---|
| $\mathbf{1}$ | $\overline{\mathbf{2}}$ | 3 | 4 |
| LIABILITIES AND CAPITAL | |||
| A) CAPITAL AND RESERVES (063+064+065+071+072+075+078) | 062 | 1.634.817.706 | 1.722.764.904 |
| I. SUBSCRIBED CAPITAL | 063 | 1.626.000.900 | 1.626.000.900 |
| II. CAPITAL RESERVES | 064 | 22.337.176 | 22.337.176 |
| III.RESERVES FROM PROFIT (066+067-068+069+070) | 065 | 59.331.755 | 51.504.850 |
| 1. Reserves prescribed by low | 066 | 19.785.012 | 20.727.012 |
| 2. Reserves for treasury shares | 067 | 35.344.592 | 35.344.592 |
| 3. Treasury stocks and shares (deduction) | 068 | 67.604.502 | 67.604.502 |
| 4. Statutory reserves | 069 | 28.036.954 | 30.705.853 |
| 5. Other reserves | 070 | 43.769.699 | 32.331.895 |
| IV. REVALUATION RESERVES | 071 | 0 | |
| V. RETAINED EARNINGS OR ACCUMULATED LOSS (073-074) | 072 | $-191.434.600$ | $-111.803.316$ |
| 1. Retained earnings | 073 | $\mathbf 0$ | |
| 2. Accumulated loss | 074 | 191.434.600 | 111.803.316 |
| VI. PROFIT/LOSS FOR THE CURRENT YEAR (076-077) | 075 | 84.235.325 | 100.430.628 |
| 1. Profit for the current year | 076 | 84.235.325 | 100.430.628 |
| 2. Loss for the current year | 077 | 0 | |
| IX. MINORITY INTERESTS | 078 | 34.347.150 | 34.294.666 |
| B) PROVISIONS (080 to 082) | 079 | 30.037.638 | 31.417.808 |
| 1. Provisions for pensions, severance pay, and similar liabilities | 080 | 22.431.979 | 22.851.669 |
| 2. Reserves for tax liabilities | 081 | 0 | |
| 3. Other reserves | 082 | 7.605.659 | 8.566.139 |
| C) LONG - TERM LIABILITIES (084 to 092) | 083 | 566.097.840 | 934.514.694 |
| 1. Liabilities to related parties | 084 | 0 | $\Omega$ |
| 2. Liabilities for loans, deposits etc. | 085 | 0 | |
| 3. Liabilities to banks and other financial institutions | 086 | 558.956.840 | 928.458.694 |
| 4. Liabilities for received prepayments | 087 | 0 | 0 |
| 5. Accounts payable | 088 | 0 | $\Omega$ |
| 6. Liabilities arising from debt securities | 089 | $\mathbf 0$ | $\mathbf 0$ |
| 7. Liabilities to entrepreneurs in whom the entity holds participating interests | 090 | 0 | $\mathbf 0$ |
| 8. Other long-term liabilities | 091 | $\Omega$ | |
| 9. Deferred tax liability | 092 | 7.141.000 | 6.056.000 |
| D) SHORT - TERM LIABILITIES (094 to 105) | 093 | 1.682.185.308 | 1.216.119.897 |
| 1. Liabilities to related parties | 094 | $\mathbf 0$ | |
| 2. Liabilities for loans, deposits etc. | 095 | 12.068 | 412.061 |
| 3. Liabilities to banks and other financial institutions | 096 | 472.129.696 | 461.843.306 |
| 4. Liabilities for received prepayments | 097 | 2.705.585 | 988,889 |
| 5. Accounts payable | 098 | 496.474.625 | 539.077.364 |
| 6. Liabilities arising from debt securities | 099 | 507.084.963 | 5.837.867 |
| 7. Liabilities to entrepreneurs in whom the entity holds participating interests | 100 | 0 | 0 |
| 8. Liabilities to employees | 101 | 61.340.528 | 59.355.642 |
| 9. Liabilities for taxes, contributions and similar fees | 102 | 13.024.738 | 14.699.857 |
| 10. Liabilities to share - holders | 103 | 686.698 | 684.699 |
| 11. Liabilities for long-term assets held for sale | 104 | ||
| 12. Other short - term liabilities | 105 | 128.726.407 | 133.220.212 |
| E) DEFFERED SETTLEMENTS OF CHARGES AND INCOME DEFERRED TO FUTURE PERIOD | 106 | 95.050.617 | 105.856.278 |
| F) TOTAL - CAPITAL AND LIABILITIES (062+079+083+093+106) | 107 | 4.008.189.109 | 4.010.673.581 |
| G) OFF-BALANCE RECORDS | 108 | 807.562.291 | 862.716.916 |
| APPENDIX to balance sheet(to be filled in by entrepreneur that prepares consolidated annual financial report) | |||
| CAPITAL AND RESERVES | |||
| 1. Attributed to equity holders of parent company | 109 | 1.600.470.556 | 1.688.470.238 |
| 2. Attributed to minority interest | 110 | 34.347.150 | 34.294.666 |
| PROFIT AND LOSS ACCOUNT |
|---|
| for the period 01.01.2011. do 30.09.2011. |
| Item | AOP code |
Last year | Current year | |||
|---|---|---|---|---|---|---|
| Comulative | Quartely | Comulative | Quartely | |||
| $\mathbf{1}$ | $\overline{2}$ | 3 | 4 | 5 | 6 | |
| I. OPERATING REVENUE (112+113) | 111 | 2.647.757.925 | 934.661.534 | 2.756.300.236 | 968.545.337 | |
| 1. Sales revenue | 112 | 2.593.831.264 | 931.093.302 | 2.690.290.194 | 966.119.459 | |
| 2. Other operating revenues | 113 | 53.926.661 | 3.568.232 | 66.010.042 | 2.425.878 | |
| II. OPERATING EXPENSES (115+116+120+124+125+126+129+130) | 114 | 2.455.699.178 | 848.532.741 | 2.560.994.837 | 876.121.351 | |
| 1. Changes in value of work in progress and finished products | 115 | $-43.828.455$ | $-36.282.149$ | $-50.667.769$ | $-33.235.428$ | |
| 2. Material costs (117 to 119) | 116 | 1.649.557.904 | 607.223.479 | 1.762.990.727 | 632.312.604 | |
| a) Raw material and material costs | 117 | 895.143.147 | 341.357.601 | 965.635.616 | 353.947.343 | |
| b) Costs of goods sold | 118 | 350.504.286 | 131.508.552 | 388,361.750 | 136.404.511 | |
| c) Other external costs | 119 | 403.910.471 | 134.357.326 | 408.993.361 | 141,960,750 | |
| 3. Staff costs (121 to 123) | 120 | 550.788.476 | 184.285.984 | 542.924.919 | 181.680.165 | |
| a) Net salaries and wages | 121 | 370.216.215 | 116.178.148 | 366.725.666 | 114.446.902 | |
| b) Cost for taxes and contributions from salaries | 122 | 114.986.296 | 43.138.085 | 111.641.338 | 42.557.681 | |
| c) Contributions on gross salaries | 123 | 65.585.965 | 24.969.751 | 64.557.915 | 24.675.582 | |
| 4. Depreciation | 124 | 116.636.938 | 38.908.736 | 117.961.616 | 39.080.070 | |
| 5. Other costs | 125 | 132.555.173 | 43.454.496 | 142.524.544 | 44.741.198 | |
| 6. Impairment (127+128) | 126 | 21.512.304 | 5.258.865 | 11.113.916 | 4.589.101 | |
| a) Impairment of long-term assets (financial assets excluded) | 127 | $\Omega$ | 0 | $\Omega$ | ||
| b) Impairment of short - term assets (financial assets excluded) | 128 | 21.512.304 | 5.258.865 | 11.113.916 | 4.589.101 | |
| 7. Provisions | 129 | 432.502 | 354.307 | 673.308 | 400.478 | |
| 8. Other operating costs | 130 | 28.044.336 | 5.329.023 | 33.473.576 | 6.553.163 | |
| III. FINANCIAL INCOME (132 to 136) | 131 | 31.921.032 | 37.181 | 33.536.422 | 7.427.890 | |
| 1. Interest income, foreign exchange gains, dividends and similar income from related | 132 | $\Omega$ | $\Omega$ | |||
| 2. Interest income, foreign exchange gains, dividends and similar income from non - | 133 | 31.891.640 | 2.063.212 | 32.537.169 | 9.088.845 | |
| 3. Share in income from affiliated entrepreneurs and participating interests | 134 | $\Omega$ | $\Omega$ | $\Omega$ | ||
| 4. Unrealized gains (income) from financial assets | 135 | 29.392 | $-2.026.031$ | 999.253 | $-1.660.955$ | |
| 5. Other financial income | 136 | $\Omega$ | $\circ$ | $\circ$ | ||
| IV. FINANCIAL EXPENSES (138 do 141) | 137 | 130.480.449 | 32.486.160 | 110,291.007 | 48.251.569 | |
| 1. Interest expenses, foreign exchange losses, dividends and similar expenses from related | 138 | $\Omega$ | 0 | $\Omega$ | ||
| 2. Interest expenses, foreign exchange losses, dividends and similar expenses from non - | 139 | 97.893.122 | 27.792.342 | 103.674.366 | 45.458.894 | |
| 3. Unrealized losses (expenses) on financial assets | 140 | 32.587.327 | 4.693.818 | 6.616.641 | 2.792.675 | |
| 4. Other financial expenses | 141 | 0 | $\mathbf{0}$ | $\circ$ | ||
| V. INCOME FROM INVESTMENT - SHARE IN PROFIT OF ASSOCIATED ENTREPRENEURS | 142 | $\Omega$ | $\circ$ | $\circ$ | ||
| VI. LOSS FROM INVESTMENT - SHARE IN LOSS OF ASSOCIATED ENTREPRENEURS | 143 | $\mathbf 0$ | 0 | $\Omega$ | ||
| VII. EXTRAORDINARY - OTHER INCOME | 144 | $\mathbf 0$ | $\mathbf{O}$ | $\circ$ | ||
| VIII. EXTRAORDINARY - OTHER EXPENSES | 145 | $\Omega$ | $\mathbf{0}$ | $\Omega$ | ||
| IX. TOTAL INCOME (111+131+142 + 144) | 146 | 2.679.678.957 | 934.698.715 | 2.789.836.658 | 975.973.227 | |
| X. TOTAL EXPENSES (114+137+143 + 145) | 147 | 2.586.179.627 | 881.018.901 | 2.671.285.844 | 924.372.920 | |
| XI. PROFIT OR LOSS BEFORE TAXATION (146-147) | 148 | 93.499.330 | 53.679.814 | 118.550.814 | 51.600.307 | |
| 1. Profit before taxation (146-147) | 149 | 93.499.330 | 53.679.814 | 118.550.814 | 51.600.307 | |
| 2. Loss before taxation (147-146) | 150 | $\Omega$ | $\Omega$ | $\circ$ | ||
| XII. PROFIT TAX | 151 | 11.315.880 | 2.983.756 | 18.382.186 | 6.846.637 | |
| XIII. PROFIT OR LOSS FOR THE PERIOD (148-151) | 152 | 82.183.450 | 50.696.058 | 100.168.628 | 44.753.670 | |
| 1. Profit for the period (149-151) | 153 | 82.183.450 | 50,696.058 | 100.168.628 | 44.753.670 | |
| 2. Loss for the period (151-148) | 154 | O | 0 | $\circ$ | ||
| APPENDIX to P&L account (to be filled in by entrepreneur that prepares consolidated financial report) | ||||||
| XIV. PROFIT OR LOSS FOR THE PERIOD | ||||||
| 1. Attributed to equity holders of parent company | 155 | 82.305.450 | 51.147.143 | 100.430.628 | 44.863.753 | |
| 2. Attributed to minority interest | 156 | $-122.000$ | $-451.085$ | $-262.000$ | $-110.083$ | |
| STATEMENT OF OTHER COMPREHENSIVE INCOME (IFRS) | ||||||
| I. PROFIT OR LOSS FOR THE PERIOD (= 152) | 157 | 82.183.450 | 50,696.058 | 100.168.628 | 44.753.670 | |
| III. OTHER COMPREHENSIVE INCOME / LOSS BEFORE TAX (159 do 165) | 158 | 8.424.253 | $-453.194$ | $-11.228.984$ | $-10.156.596$ | |
| 1. Exchange differences on translation of foreign operations | 159 | 8.424.253 | $-453.194$ | $-11.228.984$ | $-10.156.596$ | |
| 2. Movements in revaluation reserves of long - term tangible and intangible assets | 160 | |||||
| 3. Profit or loss from reevaluation of financial assets available for sale | 161 | |||||
| 4. Gains or losses on efficient cash flow hedging | 162 | |||||
| 5. Gains or losses on efficient hedge of a net investment in foreign countries | 163 | |||||
| 6. Share in other comprehensive income / loss of associated companies | 164 | |||||
| 7. Actuarial gains / losses on defined benefit plans | 165 | |||||
| III. TAX ON OTHER COMPREHENSIVE INCOME FOR THE PERIOD | 166 | |||||
| IV. NET OTHER COMPREHENSIVE INCOME OR LOSS FOR THE PERIOD (158-166) | $-453.194$ | $-11.228.984$ | ||||
| 167 | 8.424.253 | $-10.156.596$ | ||||
| V. COMPREHENSIVE INCOME OR LOSS FOR THE PERIOD (157+167) | 168 | 90.607.703 | 50.242.864 | 88.939.644 | 34.597.074 | |
| APPENDIX to Statement of other comprenhensive income (to be filled in by entrepreneur that prepares consolidated financial report) | ||||||
| VI. COMPREHENSIVE INCOME OR LOSS FOR THE PERIOD | ||||||
| 1. Attributed to equity holders of parent company | 169 | 90.744.910 | 50.519.223 | 88.992.128 | 34.473.253 | |
| 2. Attributed to minority interest | 170 | $-137.207$ | $-276.359$ | $-52.484$ | 123.821 |
STATEMENT OF CASH FLOWS - INDIRECT METHOD
for the period 01.01.2011. do 30.09.2011.
T.
| Item | AOP code |
Last year | Current year |
|---|---|---|---|
| 1 | $\overline{2}$ | 3 | 4 |
| CASH FLOW FROM OPERATING ACTIVITIES | |||
| 1. Profit before tax | 001 | 93.499.363 | 118.550.815 |
| 2. Depreciation | 002 | 116.636.939 | 117.961.616 |
| 3. Increase in short term liabilities | 003 | 51.390.636 | |
| 4. Decrease in short term receivables | 004 | 81.640.104 | |
| 5. Decrease in inventories | 005 | ||
| 6. Other increase in cash flow | 006 | 22.850.801 | 24.272.384 |
| I. Total increase in cash flow from operating activities (001 to 006) | 007 | 314.627.207 | 312.175.451 |
| 1. Decrease in short term liabilities | 008 | 123.626.000 | |
| 2. Increase in short term receivables | 009 | 27.974.719 | |
| 3. Increase in inventories | 010 | 51.531.812 | 72.939.104 |
| 4. Other decrease in cash flow | 011 | 32.375.000 | |
| II. Total decrease in cash flow from operating activities (008 to 011) | 012 | 175.157.812 | 133.288.823 |
| A1) NET INCREASE IN CASH FLOW FROM OPERATING ACTIVITIES | 013 | 139.469.395 | 178.886.628 |
| A2) NET DECREASE IN IN CASH FLOW FROM OPERATING ACTIVITIES | 014 | 0 | |
| CASH FLOW FROM INVESTING ACTIVITIES | |||
| 1. Cash inflows from sales of long-term tangible and intangible assets | 015 | 6,546,000 | 2.448.000 |
| 2. Cash inflows from sales of equity and debt instruments | 016 | 14.875.000 | 11.354.000 |
| 3. Interests receipts | 017 | 7.502.000 | 5.147.158 |
| 4. Dividend receipts | 018 | ||
| 5. Other cash inflows from investing activities | 019 | 1.402.000 | 2.466.000 |
| III. Total cash inflows from investing activities (015 to 019) | 020 | 30.325.000 | 21.415.158 |
| 1. Cash outflow for purchase of long-term tangible and intangible assets | 021 | 63.325.000 | 68.476.400 |
| 2. Cash outflow for acquisition of equity and debt financial instruments | 022 | 2.001.000 | |
| 3. Other cash outflow for investing activities | 023 | 1.219.000 | 4.861.000 |
| IV. Total cash outflow for investing activities (021 do 023) | 024 | 64.544.000 | 75.338.400 |
| B1) NET INCREASE IN CASH FLOW FROM INVESTING ACTIVITIES (020-024) | 025 | 0 | |
| B2) NET DECREASE IN CASH FLOW FROM INVESTING ACTIVITIES | 026 | 34.219.000 | 53.923.242 |
| CASH FLOW FROM FINANCIAL ACTIVITIES | |||
| 1. Cash inflow from issuing property and debt financial instruments | 027 | ||
| 2. Proceeds from the credit principal, promissory notes, borrowings and other loans | 028 | 433.781.000 | 606.707.000 |
| 3. Other proceeds from financial activities | 029 | ||
| V. Total cash inflows from financial activities (027 to 029) | 030 | 433.781.000 | 606.707.000 |
| 1. Cash outflow for repayment of credit principal and bonds | 031 | 526.898.000 | 757.293.000 |
| 2. Cash outflow for dividends paid | 032 | ||
| 3. Cash outflow for financial lease | 033 | 3.226,000 | 2.941.000 |
| 4. Cash outflow for purchase of treasury shares | 034 | ||
| 5. Other cash outflow for financial activities | 035 | ||
| VI. Total cash outflow for financial activities (031 to 035) | 036 | 530.124.000 | 760.234.000 |
| C1) NET INCREASE IN CASH FLOW FROM FINANCIAL ACTIVITIES | 037 | 0 | |
| C2) NET DECREASE IN CASH FLOW FROM FINANCIAL ACTIVITIES | 038 | 96.343.000 | 153.527.000 |
| Total increase in cash flow $(013 - 014 + 025 - 026 + 037 - 038)$ | |||
| Total decrease in cash flow (014 - 013 + 026 - 025 + 038 - 037) | 039 040 |
8.907.395 0 |
28.563.614 |
| Cash and cash equivalents at the beginning of the period | 041 | 145.269.000 | |
| Increase of cash and cash equivalents | 042 | 152.362.738 | |
| 8.907.395 | |||
| Decrease of cash and cash equivalents | 043 | 28.563.614 | |
| Cash and cash equivalents at the end of the period | 044 | 154.176.395 | 123.799.124 |
STATEMENT OF CHANGES IN EQUITY for the period 01.01.2011 do 30.09.2011
| Item | AOP code |
Last year | Current year |
|---|---|---|---|
| 1 | $\overline{2}$ | 3 | 4 |
| 1. Subscribed capital | 001 | 1.626.000.900 | 1.626.000.900 |
| 2. Capital reserves | 002 | 22.337.176 | 22.337.176 |
| 3. Reserves from profit | 003 | 59.331.755 | 51.504.850 |
| 4. Retained earnings or accumulated loss | 004 | $-191.434.600$ | $-111.803.316$ |
| 5. Profit or loss for the current year | 005 | 84.235.325 | 100.430.628 |
| 6. Revaluation of long - term tangible assets | 006 | ||
| 7. Revaluation of intangible assets | 007 | ||
| 8. Revaluation of financial assets available for sale | 008 | ||
| 9. Other revaluation | 009 | 34.347.150 | 34.294.666 |
| 10. Total capital and reserves (AOP 001 do 009) | 010 | 1.634.817.706 | 1.722.764.904 |
| 11. Currency gains and losses arising from net investement in foreign operations | 011 | 13,374,000 | $-11.438.500$ |
| 12. Current and deferred taxes (part) | 012 | ||
| 13. Cash flow hedging | 013 | ||
| 14. Changes in accounting policy | 014 | ||
| 15. Correction of significant errors in prior period | 015 | ||
| 16. Other changes of capital | 016 | 82.347.715 | 99.385.698 |
| 17. Total increase or decrease in capital (AOP 011 do 016) | 017 | 95.721.715 | 87.947.198 |
| 17 a. Attributed to equity holders of parent company | 018 | 95.735.715 | 87.999.682 |
| 17 b. Attributed to minority interest | 019 | $-14.000$ | $-52.484$ |
Notes
Main business characteristics and significant events in 2011
-
- The total sales of the Podravka Group in the first nine months of the year 2011 amounted to 2,690.3 million HRK, which represents a sales growth of 4% compared to the same period of the year before. Sales of the Strategic Business Area (SBA) Food and Beverages totalled 2,132.2 million HRK, which represented a sales growth of 3%, while the sales of the SBA Pharmaceuticals was 558.1 million HRK, which is an 8% sales increase.
-
- The operating profit (EBIT) of the Podravka Group increased by 21% and amounted to 193.5 million HRK, while the operating margin (EBIT margin) is 7.2%.
-
- The realised net profit of the Podravka Group is 100.4 million HRK, which represents a 22% increase, while the net margin is 3.7%.
-
- The total value of capital investments in the observed period amounted to 68.5 million HRK.
-
- The General Assembly of Podravka d.d. was held on 14 July 2011 where it was decided that last year's net profit in the amount of 10.9 million HRK would be distributed for the coverage of the loss brought forward from previous years. Apart from this, resolutions were passed on the amendments to the Articles of Association of Podravka d.d. and members of the Management and Supervisory Boards were discharged, accordingly.
-
- A total of 576,880 shares of Podravka d.d. in the ownership of FIMA AMI Ltd. was sold on 19 July 2011. The average price in the transaction was 312.87 HRK, and the buyers were from mandatory pension funds (75.57%), voluntary pension funds (4.27%) and other domestic funds (17.44%), insurances (1.59%) and foreign investors (1.13%).
The accounting policy in 2011 year did not change.
Koprivnica, 28 October 2011
INTERIM MANAGEMENT REPORT ON THE ACHIEVED BUSINESS RESULTS OF THE PODRAVKA GROUP FOR JANUARY - SEPTEMBER 2011 AND THE THIRD QUARTER OF THE YEAR 2011
In the period from January to September 2011 the Podravka Group achieved operating income in the amount of 2,756 million HRK, which is a 4% increase compared to the same period of the vear before.
Sales revenue of the Podravka Group amounted to 2,690.3 million HRK and are 4% higher compared to the same period of the year 2010.
Sales of the SBA Food and Beverages totalled 2,132.2 million HRK, which is a 3% sales growth compared to the same period of the year 2010. This growth was a result of a higher level of sales on foreign markets (5%), and the foreign markets which have recorded an increase of sales of the SBA Food and Beverages are South-East Europe (7%), with the most prominent markets of Bosnia and Herzegovina (6%), Serbia (14%) and Slovenia (4%), then Central Europe (6%) with the Czech Republic (16%) and Poland (4%) followed by Western Europe, overseas countries and Orient (3%), where Austria (59%) and Australia (14%) recorded the highest growth.
The SBA Pharmaceuticals achieved sales in the amount of 558.1 million HRK, which is a sales growth of 8% compared to the same period of the year 2010. Sales growth of the SBA Pharmaceuticals was mostly generated by the 16% growth on foreign markets with the highest contribution coming from the markets of Russia (26%), Bosnia and Herzegovina (10%), Slovenia (41%) and Turkey (114%). Sales on the domestic market in the observed period also grew (3%) based on a higher level of sales of prescription drugs (3%) and increased sales of the OTC programme (1%). According to the ATC classification, product groups which achieved the most significant growth are drugs with effect on the nervous system (12%) and drugs for infection system treatment (16%).
The total operating costs/expenses amounted to 2,561 million HRK and have increased by 4.3%. Material costs cover 69% of operating costs/expenses and have increased by 6.9% compared to same period of the year before. The increase of material costs was primarily influenced by higher costs of raw material and material and higher incoming prices.
Staff costs (21.2%) with a decrease of 1.4% also hold a significant share in the structure of operating costs/expenses.
PODRAVKA Inc, Koprivnica, Ante Starčevića 32, The Commercial Court Varaždin, MBS: 010006549, PIN: 18928523252, foundation capital: 1.626.000.900,00 kunas, paid in full, total number of shares issued: 5.420.003, nominal share value: 300.00 kunas, Privredna banka Zagreb d. d.. Zagreb, Račkoga 6, bank account: 2340009-1100098526, president of the Supervisory Board: Lj. Jurčić, president of the Management Board M. Vitković,
members of the Management Board K. Bešvir, L. Kljajić, M. Pucar, M. Repić
COMPANY MANAGEMENT
The realised net profit is 100.4 million HRK and is 22% higher than the realised net profit of the same period the year before. The recovery of insurance funds within the SBA Pharmaceuticals in the amount of 23.7 million HRK had significant effect on the realised net profit.
Operating income in the amount of 968.5 million HRK was realised in the third quarter of which 966 million HRK refers to sales revenue, which increased by 4% compared to the same quarter of last year.
Operating costs/expenses in the third quarter amounted to 876.1 million HRK and have increased by 3% compared to the same period of the year before.
The realised net profit of the third quarter is 44.8 million HRK.
The total value of assets of the Podravka Group as of 30 September 2011 is 4,011 million HRK and remains almost unchanged compared to the year end balance of 2010. The structure of assets has changed as the value of non-current assets decreased by 50.9 million HRK, while at the same time current assets increased by 51.4 million HRK.
Inventories (73.4 million HRK) and receivables (35.0 million HRK) have increased within the structure of current assets. Short-term financial assets have been reduced by 28.4 million HRK as well as the balance of cash and cash equivalents by 28.6 million HRK compared to the year end of 2010.
The total indebtedness of the Podravka Group in the period from January to September of the current year has been reduced by 131.2 million HRK (from 1.511 million HRK as of 31 December 2010 to 1,380 million HRK as of 30 September 2011). The net debt amounts to 1,256 million HRK.
President of the Mana $\phi$ ement Board:
COMPANY MANAGEMENT
Koprivnica, 28, October 2011
STATEMENT FROM EXECUTIVES RESPONSIBLE FOR PREPARING FINANCIAL STATEMENTS
Consolidated and unaudited financial statements of the Podravka Group for the period January -September 2011 have been prepared in compliance with the Accounting Act of the Republic of Croatia and International Financial Reporting Standards (IFRS) and provide an overall and true presentation of assets, liabilities, profit and loss, financial position and business operations of the Group and all related companies involved in the consolidation.
During the observed period, there were no changes in accounting policies of the Podravka Group.
Accounting Director: Draga Celiščak Chricall Do
Board Member for Finance: Lidija Kljajić